Sfoglia per Rivista ONCOIMMUNOLOGY
Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing mesenchymal transition.
2018-01-01 Siddiqui, I; Erreni, M; Kamal, Ma; Porta, C; Marchesi, F; Pesce, S; Pasqualini, F; Schiarea, S; Chiabrando, C; Mantovani, A; Allavena, P.
Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer: Implications for immunotherapy
2016-01-01 Pinato, D. J.; Shiner, R. J.; White, S. D. T.; Black, J. R. M.; Trivedi, P.; Stebbing, J.; Sharma, R.; Mauri, F. A.
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment
2015-01-01 Parodi, Monica; Pedrazzi, Marco; Cantoni, Claudia; Averna, Monica; Patrone, Mauro; Cavaletto, Maria; Spertino, Stefano; Pende, Daniela; Balsamo, Mirna; Pietra, Gabriella; Sivori, Simona; Carlomagno, Simona; Mingari, Maria Cristina; Moretta, Lorenzo; Sparatore, Bianca; Vitale, Massimo
PKR and GCN2 stress kinases promote an ER stress-independent eIF2α phosphorylation responsible for calreticulin exposure in melanoma cells
2018-01-01 Giglio, P; Gagliardi, M; Tumino, N; Antunes, F; Smaili, S; Cotella, D; Santoro, C; Bernardini, R; Mattei, M; Piacentini, M; Corazzari, M
Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior
2017-01-01 Pinato, D. J.; Black, J. R.; Trousil, S.; Dina, R. E.; Trivedi, P.; Mauri, F. A.; Sharma, R.
Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study
2017-01-01 Mletzko, S.; Pinato, D. J.; Robey, R. C.; Dalla Pria, A.; Benson, P.; Imami, N.; Bower, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing mesenchymal transition. | 1-gen-2018 | Siddiqui, I; Erreni, M; Kamal, Ma; Porta, C; Marchesi, F; Pesce, S; Pasqualini, F; Schiarea, S; Chiabrando, C; Mantovani, A; Allavena, P. | |
| Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer: Implications for immunotherapy | 1-gen-2016 | Pinato, D. J.; Shiner, R. J.; White, S. D. T.; Black, J. R. M.; Trivedi, P.; Stebbing, J.; Sharma, R.; Mauri, F. A. | |
| Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment | 1-gen-2015 | Parodi, Monica; Pedrazzi, Marco; Cantoni, Claudia; Averna, Monica; Patrone, Mauro; Cavaletto, Maria; Spertino, Stefano; Pende, Daniela; Balsamo, Mirna; Pietra, Gabriella; Sivori, Simona; Carlomagno, Simona; Mingari, Maria Cristina; Moretta, Lorenzo; Sparatore, Bianca; Vitale, Massimo | |
| PKR and GCN2 stress kinases promote an ER stress-independent eIF2α phosphorylation responsible for calreticulin exposure in melanoma cells | 1-gen-2018 | Giglio, P; Gagliardi, M; Tumino, N; Antunes, F; Smaili, S; Cotella, D; Santoro, C; Bernardini, R; Mattei, M; Piacentini, M; Corazzari, M | |
| Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior | 1-gen-2017 | Pinato, D. J.; Black, J. R.; Trousil, S.; Dina, R. E.; Trivedi, P.; Mauri, F. A.; Sharma, R. | |
| Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study | 1-gen-2017 | Mletzko, S.; Pinato, D. J.; Robey, R. C.; Dalla Pria, A.; Benson, P.; Imami, N.; Bower, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile